Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received October 12, 2012
- Accepted after revision December 16, 2012
- Published online September 10, 2013.
Article Versions
- Latest version (April 11, 2013 - 08:14).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2013 by American Journal of Neuroradiology Indicates open access to non-subscribers at www.ajnr.org
Author Information
- P.D. Kotharia,
- N.S. Whiteb,e,
- N. Faridb,e,
- R. Chungb,
- J.M. Kupermanb,e,
- H.M. Girarde,
- A. Shankaranarayanang,
- S. Kesaric,f,
- C.R. McDonaldd,e and
- A.M. Daleb,c,d,e
- aFrom the School of Medicine (P.D.K.)
- bDepartments of Radiology (N.S.W., N.F., R.C., J.M.K., A.M.D.)
- cNeurosciences (S.K., A.M.D.)
- dPsychiatry (C.R.M., A.M.D.)
- eMultimodal Imaging Laboratory (N.S.W., N.F., J.M.K., H.M.G., C.R.M., A.M.D.)
- fTranslational Neuro-Oncology Laboratories (S.K.), Moores Cancer Center; University of California, San Diego, La Jolla, California
- gGE Healthcare (A.S.), Milwaukee, Wisconsin.
- Please address correspondence to C.R. McDonald, MD, Multimodal Imaging Laboratory, Ste C101, 8950 Villa La Jolla Dr, La Jolla, CA 92037; e-mail: camcdonald{at}ucsd.edu
Altmetrics
Cited By...
Jump to section
Related Articles
Cited By...
- Characterization of the Diffusion Signal of Breast Tissues using Multi-exponential Models
- Edge Contrast of the FLAIR Hyperintense Region Predicts Survival in Patients with High-Grade Gliomas following Treatment with Bevacizumab
- Lessons From Anti-Vascular Endothelial Growth Factor and Anti-Vascular Endothelial Growth Factor Receptor Trials in Patients With Glioblastoma
- Diffusion-Weighted Imaging in Cancer: Physical Foundations and Applications of Restriction Spectrum Imaging
- Advanced Magnetic Resonance Imaging of the Physical Processes in Human Glioblastoma
- Pretreatment ADC Histogram Analysis Is a Predictive Imaging Biomarker for Bevacizumab Treatment but Not Chemotherapy in Recurrent Glioblastoma